Category: AngioDynamics Inc.
AngioDynamics names Joseph DeVivo as its new CEO, replacing Jan Keltjens, and reveals the departure of one of its senior business development executives.
AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.
The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.
AngioDynamics lets U.S. sales general manager Alan Panzer go "without cause."
keys: angiodynamics, cfo, alan panzer
Albany, N.Y.-based AngioDynamics (NSDQ:ANGO) said Alan Panzer, its general manager of U.S. sales, will no longer be with the company as of July 31, 2013.
Medical device industry lobbying group AdvaMed is turning to those employed at medtech companies to spur more activity in efforts to repeal a 2.3% excise tax that took effect at the start of the year.
Changing expectations affect investors despite unchanged fundamentals: Weaker underlying volumes.
By Stephen Simpson
Medical device reviewers at the Center for Devices & Radiological Health at the FDA will tour medical device manufacturing facilities as part of their training.
MASSDEVICE ON CALL — The FDA is looking for medical device companies to participate in its "Experiential Learning Program," so that the agency's reviewers can get a 1st-hand look into medtech design and manufacturing.
Participating companies would host tours for healthcare regulators as part of a training mechanism to give the reviewers a sense of the medtech development life-cycle and the "challenges faced throughout development, testing, manufacturing, and clinical use," according to an FDA notice.
Medical device company AngioDynamics' executive VP & CFO retires after holding his position for 5 years.
AngioDynamics loses EVP & CFO
Albany, N.Y.-based AngioDynamics' executive vice president & CFO Joseph Gersuk retired from the company, effective January 31, 2013.